Xilio Therapeutics Inc (XLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 2,263 | 2,357 | 0 | 0 | 0 |
| Gross Profit | 2,263 | 2,357 | N/A | N/A | N/A |
| Operating Expenses | 17,025 | 17,061 | 17,487 | 18,130 | 17,361 |
| Operating Income | -14,762 | -14,704 | -17,487 | -18,130 | -17,361 |
| Other Income | 742 | 779 | 284 | 475 | 613 |
| Pre-tax Income | -14,020 | -13,925 | -17,203 | -17,655 | -16,748 |
| Net Income Continuous | -14,020 | -13,925 | -17,203 | -17,655 | -16,748 |
| Net Income | $-14,020 | $-13,925 | $-17,203 | $-17,655 | $-16,748 |
| EPS Basic Total Ops | -3.08 | -3.36 | -8.68 | -8.96 | -8.54 |
| EPS Basic Continuous Ops | -3.09 | -3.38 | -8.63 | -8.97 | -8.52 |
| EPS Diluted Total Ops | -3.08 | -3.36 | -8.68 | -8.96 | -8.54 |
| EPS Diluted Continuous Ops | -3.09 | -3.38 | -8.63 | -8.97 | -8.52 |
| EPS Diluted Before Non-Recurring Items | -3.08 | -3.36 | -8.26 | N/A | N/A |
| EBITDA(a) | $-14,382 | $-14,259 | $-17,044 | $-17,681 | $-16,901 |